Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 67.81m |
Free float | 48.58m |
P/E (TTM) | -- |
Market cap | 2.20bn SEK |
EPS (TTM) | -11.34 SEK |
Data delayed at least 15 minutes.
More ▼
Press releases
- Hansa Biopharma to Attend Truist Securities BioPharma Symposium
- Hansa Biopharma Reports Third Quarter and Interim January - September 2024 Financial Results
- Hansa Biopharma's HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial
- Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis
More ▼